Literature DB >> 2513569

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

G Gross1, T Waks, Z Eshhar.   

Abstract

To design and direct at will the specificity of T cells in a non-major histocompatibility complex (MHC)-restricted manner, we have generated and expressed chimeric T-cell receptor (TcR) genes composed of the TcR constant (C) domains fused to the antibody's variable (V) domains. Genomic expression vectors have been constructed containing the rearranged gene segments coding for the V region domains of the heavy (VH) and light (VL) chains of an anti-2,4,6-trinitrophenyl (TNP) antibody (SP6) spliced to either one of the C-region gene segments of the alpha or beta TcR chains. Following transfection into a cytotoxic T-cell hybridoma, expression of a functional TcR was detected. The chimeric TcR exhibited the idiotope of the Sp6 anti-TNP antibody and endowed the T cells with a non-MHC-restricted response to the hapten TNP. The transfectants specifically killed and produced interleukin 2 in response to TNP-bearing target cells across strain and species barriers. Moreover, such transfectants responded to immobilized TNP-protein conjugates, bypassing the need for cellular processing and presentation. In the particular system employed, both the TNP-binding site and the Sp6 idiotope reside almost exclusively in the VH chain region. Hence, introduction into T cells of TcR genes containing only the VHSp6 fused to either the C alpha or C beta was sufficient for the expression of a functional surface receptor. Apparently, the VHC alpha or VHC beta chimeric chains can pair with the endogenous beta or alpha chains of the recipient T cell to form a functional alpha beta heterodimeric receptor. Thus, this chimeric receptor provides the T cell with an antibody-like specificity and is able to effectively transmit the signal for T-cell activation and execution of its effector function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513569      PMCID: PMC298636          DOI: 10.1073/pnas.86.24.10024

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  A novel approach for preparing anti-T cell receptor constant region antibodies.

Authors:  A Traunecker; B Dolder; K Karjalainen
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

3.  Variability and repertoire size of T-cell receptor V alpha gene segments.

Authors:  D M Becker; P Pattern; Y Chien; T Yokota; Z Eshhar; M Giedlin; N R Gascoigne; C Goodnow; R Wolf; K Arai
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

4.  Transmission and expression of a specific pair of rearranged immunoglobulin mu and kappa genes in a transgenic mouse line.

Authors:  S Rusconi; G Köhler
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

Review 5.  The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition.

Authors:  M Kronenberg; G Siu; L E Hood; N Shastri
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors.

Authors:  R Baer; K C Chen; S D Smith; T H Rabbitts
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

7.  Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production.

Authors:  A Ochi; R G Hawley; M J Shulman; N Hozumi
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

8.  Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences.

Authors:  R G Hawley; M J Shulman; H Murialdo; D M Gibson; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

10.  A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci.

Authors:  C T Denny; Y Yoshikai; T W Mak; S D Smith; G F Hollis; I R Kirsch
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  437 in total

Review 1.  Immunotherapy for primary brain tumors: no longer a matter of privilege.

Authors:  Peter E Fecci; Amy B Heimberger; John H Sampson
Journal:  Clin Cancer Res       Date:  2014-11-15       Impact factor: 12.531

2.  Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition.

Authors:  R K Ganju; S T Smiley; J Bajorath; J Novotny; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 3.  Adapting antibodies for clinical use.

Authors:  R E Hawkins; M B Llewelyn; S J Russell
Journal:  BMJ       Date:  1992-11-28

4.  A new cellular weapon to kill leukaemic B-cells.

Authors:  Mohamed-Rachid Boulassel
Journal:  Sultan Qaboos Univ Med J       Date:  2012-04-09

Review 5.  Raising the bar: the curative potential of human cancer immunotherapy.

Authors:  Steven A Rosenberg
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

Review 6.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

7.  Engineering T cells for cancer: our synthetic future.

Authors:  Robert H Vonderheide; Carl H June
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine.

Authors:  Michael R Weist; Renate Starr; Brenda Aguilar; Junie Chea; Joshua K Miles; Erasmus Poku; Ethan Gerdts; Xin Yang; Saul J Priceman; Stephen J Forman; David Colcher; Christine E Brown; John E Shively
Journal:  J Nucl Med       Date:  2018-05-04       Impact factor: 10.057

Review 9.  Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.

Authors:  Thomas Shum; Robert L Kruse; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2018-05-14       Impact factor: 4.388

Review 10.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.